Controlled-release of apatinib for targeted inhibition of osteosarcoma by supramolecular nanovalve-modified mesoporous silica

Overview of attention for article published in Frontiers in Bioengineering and Biotechnology, February 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,204 followers.

RT @FrontBioeng: New Research: Controlled-release of apatinib for targeted inhibition of osteosarcoma by supramolecular nanovalve-modified…

17 Feb 2023

Reply Repost Favourite

New Research: Controlled-release of apatinib for targeted inhibition of osteosarcoma by supramolecular nanovalve-modified mesoporous silica https://t.co/mm9Gez9252 #bioengineering #biotech

17 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.